Bispecifics Strapline Banner

14th World Bispecific Summit

2023 Is The Year of Bispecific Antibody Treatments

Going head to head with Cell Therapy, Bispecific antibody treatments have never been more promising, with the last year seeing more and more assets moving through the clinic, gaining regulatory approval and expanding to treat a wider range of indications.

The World Bispecific Summit returns for its 14th year with an enriched program boasting comprehensive coverage of all the key discovery, pre-clinical and clinical challenges including design, clinical, regulatory and combination strategies. Led by the industries brightest minds from the likes of Sanofi, Regeneron, the FDA, Alligator Biosciences and Amgen, it’s the perfect platform to celebrate wins, work through challenges and establish connections with the leading pharma, biotech and academic KOLs.

Deep dive into novel target selection, immune cell modulators, target selection and pre-clinical/clinical readouts and gain holistic insight of the current state-of-play in the bispecific landscape to  supercharge your own pipeline from discovery through to IND approval.

Among Our World-Class Speaker Faculty

2023 Experts Included:

What Previous Attendees Have Said

“Focused on topics that matter. Top speakers. The best conference in the field in my opinion.”

"An excellent opportunity to learn about the latest developments in the bispecific antibody field."
Boehringer Ingelheim

"Great speakers, great networking, and stimulating discussions!"

"Informative and energizing opportunity to hear about the latest advances in bispecific antibodies from the leaders in the field"

"Engaging science and a variety of strong presentations and discussions highlighting innovative approaches that are being implemented and tested in the rapidly developing field of bispecific"
Eli Lilly & Co.

"Fantastic place to connect with all the top bispecific players"
KBI Biopharma

Our 2023 Partners